A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

Clinical trial NCT06025773 · COMPLETED

Trial details

NCT number: NCT06025773
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastro Esophageal Reflux

Start date: 2023-09-15
Primary completion: 2024-04-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.